Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars

• Published in: American journal of ophthalmology Vol. 236; pp. 20 - 31
• Main Authors: Yu, Angeli Christy, Spena, Rossella, Fusco, Fiorella, Dondi, Riccardo, Myerscough, James, Fabbri, Federica, Bovone, Cristina, Busin, Massimo
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2022; Elsevier Limited
• Subjects: Astigmatism; Biometrics; Cornea; Corneal Injuries - complications; Corneal Injuries - surgery; Corneal Transplantation; Dissection; Endothelium; Endothelium, Corneal; Eye surgery; Humans; Keratoplasty, Penetrating; Microscopy; Patients; Refraction, Ocular; Scars; Surgical outcomes; Surgical techniques; Sutures; Treatment Outcome; Visual Acuity; Italy
• ISSN: 0002-9394; 1879-1891
• DOI: 10.1016/j.ajo.2021.09.036

To report the outcomes of 2-piece microkeratome-assisted mushroom keratoplasty (MK) for eyes with full-thickness traumatic corneal scars and otherwise functional endothelium following corneal penetrating injury.
This was an interventional case series.
In this single-center study, 41 consecutive eyes with traumatic corneal scars that underwent 2-piece microkeratome-assisted mushroom keratoplasty were evaluated. The 2-piece mushroom graft consisted of an anterior lamella 9 mm in diameter and a posterior lamella 6 mm in diameter. Outcome measures were best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), endothelial cell density, and postoperative complication rates.
Of the 41 total cases, 38 eyes (93%) reached Snellen vision ≥20/100, 36 (88%) reached ≥20/60, 29 (71%) reached ≥20/40, and 13 (32%) reached ≥20/25 2 years following MK. Excluding eyes with vision-impairing comorbidities, baseline logMAR BSCVA (1.41 ± 0.73) significantly improved annually during the first 2 years (P < 0.001), reaching 0.16 ± 0.13 at year 2, which subsequently remained stable up to 10 years (P = .626). The RA exceeded 4.5 diopters in 2 cases (5%) after wound revision for high-degree astigmatism in 5 cases. Endothelial cell loss was 35.1% at 1 year, with an annual decline of 2.9% over 10 years. Elevation in IOP was observed postoperatively in 7 eyes, of which 6 had pre-existing glaucoma. The 10-year cumulative risk for graft rejection and failure was 8.5% and 10%, respectively.
Two-piece microkeratome-assisted MK for traumatic corneal scars can allow excellent visual rehabilitation with relatively stable ECL and low rates of immunologic rejection and graft failure.